- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06461884
Combined Effects Of Percussion With Diaphragmatic Breathing Exercises On Airway Clearance In Elderly Pneumonia Patients
June 12, 2024 updated by: Riphah International University
Combined Effects of Percussion With Diaphragmatic Breathing Exercises on Airway Clearance in Elderly Pneumonia Patients
The group A will receive percussions and diaphragmatic breathing with 1 session a day for 3 days in a week for 4 weeks.
In this way total 12 sessions will be given to the patients.
And group B will receive only diaphragmatic breathing with 1 session a day for total 3 days in a week for 4 weeks.
By this intervention procedure, I will find out the effects of these techniques on airway clearance of the pneumonia patients, their effect on the quality of life and on Dyspnea.
For this I will use 4 tool questionnaires that are 1-BCSS, 2- Modified Borg Dyspnea scale, 3-Rate of perceived exertion scale, 4- Health-related Quality of Life-14.
BCSS will be used to assess breathlessness, cough and sputum retention.
Modified Borg Dyspnea scale is 0-10 rated numerical scale used to measure Dyspnea.
RPE is a way to measure the level of exertion a person feels during physical activity.
HRQOL-14 will assess the quality of life of the pneumonia patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
It will be a randomized clinical trial.
And the data will be conducted from Mayo Hospital Lahore.
Convenient sampling technique will be applied on patients according to the inclusion criteria.
Patients will be allocated through simple random sampling into group A and group B to collect data.
For this purpose, I will divide my sample size into two groups.
The group A will receive percussions and diaphragmatic breathing with 1 session a day for 3 days in a week for 4 weeks.
In this way total 12 sessions will be given to the patients.
And group B will receive only diaphragmatic breathing with 1 session a day for total 3 days in a week for 4 weeks.
By this intervention procedure, I will find out the effects of these techniques on airway clearance of the pneumonia patients, their effect on the quality of life and on Dyspnea.
For this I will use 4 tool questionnaires that are 1-BCSS, 2- Modified Borg Dyspnea scale, 3-Rate of perceived exertion scale, 4- Health-related Quality of Life-14.
BCSS will be used to assess breathlessness, cough and sputum retention.
Modified Borg Dyspnea scale is 0-10 rated numerical scale used to measure Dyspnea.
RPE is a way to measure the level of exertion a person feels during physical activity.
HRQOL-14 will assess the quality of life of the pneumonia patients.
Before and after each session, the primary and secondary outcomes will be measured for both groups.
After collecting the data, the data will be analyzed by using SPSS version 25.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Imran Amjad, PhD
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Contact Backup
- Name: Iqbal Tariq, PHD
- Phone Number: O3338236752
- Email: iqbal.tariq@riphah.edu.pk
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- Recruiting
- Mayo Hospital Lahore
-
Contact:
- Sidra Faisal, MS.CPPT
- Phone Number: 03022001847
- Email: sidra.faisal@riphah.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Patients aged 40-60,
- Both males and females
- Those patients who will be vitally stable (oxygen saturation, respiratory rate)
- Pneumonia diagnosed patients (Community Acquired Pneumonia)
Exclusion Criteria:
Patients with heart disease
- Patients with neurological disorders such as: Alzheimer, epilepsy, Parkinson disease
- Patients with orthopedic conditions
- Other pulmonary complications (atelectasis, diaphragmatic injury, ARDS)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Percussions
Group A: Percussions and diaphragmatic breathing exercise will be performed with 1 session a day for total 3 days in a week for 4 weeks
|
Group A: Percussions and diaphragmatic breathing exercise will be performed with 1 session a day for total 3 days in a week for 4 weeks
|
|
Experimental: Diaphragmatic breathing exercise
Group B: Diaphragmatic breathing exercise will be performed with 1 session a day for total 3 days in a week for 4 weeks
|
Group B: Diaphragmatic breathing exercise will be performed with 1 session a day for total 3 days in a week for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BCSS
Time Frame: 4 weeks
|
BCSS: BCSS is a patient-reported three-item questionnaire for cough, breathlessness and sputum rating on a 5-point Likert scale from 0 (no symptoms) to 4 (severe symptoms).
|
4 weeks
|
|
HRQOL for quality of life
Time Frame: 4 weeks
|
One of the many factors frequently investigated in the realm of medical research and treatment is HRQOL.
It covers a broad spectrum of man experience, contains how we operate and how we perceive illness.
The World Health Organization defines health as a condition of whole physical, intellectual, and interpersonal well-being and not just the absence of disease, which is the foundation for modern interpretations of HRQOL.
|
4 weeks
|
|
Rated Perceived Exertion (RPE) Scale
Time Frame: 4 weeks
|
Rate of perceived exertion (RPE) is used to measure how hard your body works during physical activity.
It runs from 0 - 10, using numbers to rate how much effort an activity takes.
The RPE scale can help you manage exercise intensity and improve cardio training and endurance
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sidra Faisal, PP-DPT, Riphah International University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004 Dec 1;39(11):1642-50. doi: 10.1086/425615. Epub 2004 Nov 8.
- Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011 Feb;5(1):61-78. doi: 10.1177/1753465810381518. Epub 2010 Oct 8.
- Marchello CS, Ebell MH, Dale AP, Harvill ET, Shen Y, Whalen CC. Signs and Symptoms That Rule out Community-Acquired Pneumonia in Outpatient Adults: A Systematic Review and Meta-Analysis. J Am Board Fam Med. 2019 Mar-Apr;32(2):234-247. doi: 10.3122/jabfm.2019.02.180219.
- Miyashita N, Yamauchi Y. Bacterial Pneumonia in Elderly Japanese Populations. Jpn Clin Med. 2018 Jan 3;9:1179670717751433. doi: 10.1177/1179670717751433. eCollection 2018.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2024
Primary Completion (Estimated)
July 15, 2024
Study Completion (Estimated)
July 15, 2024
Study Registration Dates
First Submitted
June 12, 2024
First Submitted That Met QC Criteria
June 12, 2024
First Posted (Actual)
June 17, 2024
Study Record Updates
Last Update Posted (Actual)
June 17, 2024
Last Update Submitted That Met QC Criteria
June 12, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/23/0379
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial PneumoniaChina
Clinical Trials on Percussions
-
Riphah International UniversityCompleted
-
University of Health Sciences LahoreNot yet recruiting